Background illustration for clinical trials search

Paid Clinical Trials Edmond

Discover 573 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

for
Small Cell Lung Cancer, Advanced Solid Malignant Tumor
Location: Oklahoma City OK, Huntsville TX, Nashville TN,
Sponsor: Chipscreen Biosciences, Ltd.

Sex: All

Age: 18+

Code: NCT05271292

Phase 1, Phase 2, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Oklahoma City OK, Houston TX, New Lenox IL,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase 2, Recruiting

Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT

for
Patent Ductus Arteriosus After Premature Birth
Location: Oklahoma City OK, Orange CA, Edmonton, Quebec City,
Sponsor: IWK Health Centre

Sex: All

Age: 0

Code: NCT05011149

Phase 3, Recruiting

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

for
Post Operative Surgical Site Infection
Location: Oklahoma City OK, Houston TX, Jackson MS, Aurora CO,
Sponsor: Major Extremity Trauma Research Consortium

Sex: All

Age: 18 - 64

Code: NCT04678154

Phase 3, Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Oklahoma City OK, Fort Worth TX, Kansas City MO,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Oklahoma City OK, Tulsa OK, Dallas TX, Fort Worth TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Oklahoma City OK, Houston TX, Aurora CO,
Sponsor: Mannkind Corporation

Sex: All

Age: 6 - 17

Code: NCT07224321

Phase 2, Recruiting

Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors

for
Prostate Cancer
Location: Oklahoma City OK, Milledgeville GA, Tallahassee FL
Sponsor: University of Oklahoma

Sex: Male

Age: 18+

Code: NCT06651359

Recruiting

Neuromodulation of Inflammation and Endothelial Function

for
Systolic Heart Failure
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT05230732

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase 2, Recruiting

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

for
Diabetes Mellitus, Atrial Fibrillation
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT05174052

Phase 3, Recruiting

Endothelial Derived Hyperpolarization Factor and Vascular Control

for
Healthy
Location: Norman OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 30

Code: NCT05176379

Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Oklahoma City OK, Tulsa OK, Dallas TX, Kansas City KS,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Oklahoma City OK, Albuquerque NM, Iowa City IA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase 1, Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for
Acute Myeloid Leukemia,
Location: Oklahoma City OK, Overland Park KS, Fairway KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase 1, Recruiting

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

for
Vulvar Cancer, Sentinel Lymph Node, Lymph Node Metastases
Location: Oklahoma City OK, Omaha NE, Sioux Falls SD,
Sponsor: University Medical Center Groningen

Sex: Female

Age: 18+

Code: NCT05076942

Phase 2, Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Oklahoma City OK, Omaha NE, Houston TX, St Louis MO,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase 2, Recruiting

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

for
Respiratory Syncytial Virus Infections
Location: Oklahoma City OK, Dallas TX, Omaha NE, St Louis MO,
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 0 - 2

Code: NCT05026749

Phase 3, Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

for
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Location: Oklahoma City OK, Richardson TX, Dallas TX,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT05646316

Phase 3, Recruiting

IV Ensure in Patients Receiving OPAT

for
Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates,
Location: Oklahoma City OK
Sponsor: IV Ensure

Sex: All

Age: 18+

Code: NCT06623318

Recruiting